Johnson & Johnson’s single-dose vaccine found to be 66% effective in global trial

Johnson & Johnson’s single-dose vaccine found to be 66% effective in global trial

Post Desk : A single-dose Covid-19 vaccine by Johnson & Johnson has proved to be be 66 per cent